Citigroup Lowers PT On Human Genome Sciences To $15

Symbols: HGSI
Tags: Citigroup
Share

Citigroup has lowered the price target on Human Genome Sciences (NASDAQ: HGSI) from $26 to $15 and maintains its Hold rating.


 
 
< Previous
Wunderlich Initiates Constant Contact At Buy, $38 PT
Next >
Morgan Keegan Lowers PT On UTi Worldwide To $18
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust